CD8A and B-cell chronic lymphocytic leukemia: But based on the very small patient cohort in this study and recent findings showing that CD8+ T-cells derived from lymphoid organs of CLL patients are more active than their blood-derived counterparts (149, 152), the provided analysis of blood T-cells during idelalisib-treatment allows only for very limited conclusions.